For cholesterol drug Vytorin, success has come in pairs. A dual mechanism of action, a harmonious partnership between Merck and Schering-Plough, and twin-themed creative combined to help Vytorin more than double growth last year.
Hard to believe that only a couple years ago, analysts were saying last rites for Merck Co. as a plague of trial lawyers sized up their prey, visions of multi-million dollar billings dancing in their heads.
Curry Rockefeller Group adds Troy-Ott as project director
January 1, 2007
5:00 am
The Curry Rockefeller Group has added Patti Troy-Ott, MA, as project director.
MedConference redesigns Web site
January 1, 2007
5:00 am
Healthcare Web conferencing firm MedConference, a wholly owned subsidiary of inVentiv Health, says it has redesigned its Web site to accommodate a growing demand for customized online events among the life sciences industry.
WebMD reports 55% more CME programs completed in 3Q
January 1, 2007
5:00 am
WebMD says during the third quarter, 487,000 CME programs were completed on its professional site, an increase of 55% compared to the previous year.
ProMutual Group achieves ACCME accreditation
January 1, 2007
5:00 am
ProMutual Group says it has achieved ACCME accreditation, joining a small group of 11 US medical liability insurers accredited as of 2005.
CME funding report due to be released
January 1, 2007
5:00 am
The Society for Academic Continuing Medical Education says its biannual report is due out this month after a delay.
Pri-Med released findings from a CME outcomes study it says includes feedback from nearly 50,000 medical professionals and a wealth of information on specific disease states.